Evli Oyj (HEL:EVLI)

Market Cap	516.46M
Revenue (ttm)	119.10M
Net Income (ttm)	30.80M
Shares Out	26.48M
EPS (ttm)	1.13
PE Ratio	17.28
Forward PE	15.35
Dividend	1.18 (6.07%)
Ex-Dividend Date	Mar 19, 2025

Volume	20
Average Volume	1,797
Open	19.50
Previous Close	19.50
Day's Range	19.40 - 19.50
52-Week Range	15.25 - 20.00
Beta	0.36
RSI	61.55
Earnings Date	Oct 24, 2025

About Achilles Therapeutics

Evli Oyj, together with its subsidiaries, operates as an asset manager serving corporate, institutional, and private clients in Finland, Sweden, and internationally. It operates through two segments, Wealth Management and Investor Clients; and Advisory and Corporate Clients. The company offers institutional and aurator asset management; corporate and capital management services, including M&A advisory services on acquisitions and divestments, IPOs, and share issues; and corporate analysis services for listed companies. It also provides custody,...

• Industry: Asset Management
• Sector: Financials
• Founded: 1985
• Employees: 305
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: EVLI

Financial Performance

In 2024, Evli Oyj's revenue was 122.30 million, an increase of 6.53% compared to the previous year's 114.80 million. Earnings were 44.60 million, an increase of 54.86%.